184 related articles for article (PubMed ID: 31251824)
1. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
Sheu JJ; Tsai MT; Erickson SR; Wu CH
Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
[TBL] [Abstract][Full Text] [Related]
3. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.
Gray SL; Anderson ML; Dublin S; Hanlon JT; Hubbard R; Walker R; Yu O; Crane PK; Larson EB
JAMA Intern Med; 2015 Mar; 175(3):401-7. PubMed ID: 25621434
[TBL] [Abstract][Full Text] [Related]
4. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
Lee EK; Lee YJ
Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
[TBL] [Abstract][Full Text] [Related]
5. Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease.
Hong CT; Chan L; Wu D; Chen WT; Chien LN
Parkinsonism Relat Disord; 2019 Aug; 65():224-229. PubMed ID: 31255536
[TBL] [Abstract][Full Text] [Related]
6. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
Joung KI; Shin JY; Cho SI
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
[TBL] [Abstract][Full Text] [Related]
7. Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: a nationwide 12-year cohort study.
Wang YC; Chen YL; Huang CC; Ho CH; Huang YT; Wu MP; Ou MJ; Yang CH; Chen PJ
BMC Geriatr; 2019 Dec; 19(1):380. PubMed ID: 31888519
[TBL] [Abstract][Full Text] [Related]
8. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.
Kalisch Ellett LM; Pratt NL; Ramsay EN; Barratt JD; Roughead EE
J Am Geriatr Soc; 2014 Oct; 62(10):1916-22. PubMed ID: 25284144
[TBL] [Abstract][Full Text] [Related]
9. Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale.
Suh Y; Ah YM; Han E; Jun K; Hwang S; Choi KH; Lee JY
BMC Geriatr; 2020 Jul; 20(1):265. PubMed ID: 32727410
[TBL] [Abstract][Full Text] [Related]
10. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
13. Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
Ah YM; Suh Y; Jun K; Hwang S; Lee JY
Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):741-748. PubMed ID: 30511428
[TBL] [Abstract][Full Text] [Related]
14. Impact of Multiple Prescriptions With Anticholinergic Properties on Adverse Clinical Outcomes in the Elderly: A Longitudinal Cohort Study in Taiwan.
Hsu WH; Huang ST; Lu WH; Wen YW; Chen LK; Hsiao FY
Clin Pharmacol Ther; 2021 Oct; 110(4):966-974. PubMed ID: 33626177
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
16. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
[TBL] [Abstract][Full Text] [Related]
17. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic burden in Parkinson's disease inpatients.
Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
[TBL] [Abstract][Full Text] [Related]
20. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
